Announce Date | 02/13/2024 |
EPS Normalized Actual | $-0.3 In Line |
EPS GAAP Actual | $-0.3 In Line |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 06/30/2024 (Pre-Market) |
EPS Normalized Estimate | $1.34259 |
EPS GAAP Estimate | $1.34259 |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Mar 2028 | 0.8009 | 3.45 | 0.8009 | 0.8009 | 1 |
Mar 2027 | -1.267 | -2.18 | -1.267 | -1.267 | -1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | -0.09 | -0.04 | 0B | -INF% | 0M |
FQ3 2021 (Sep 2021) | 0.03 | 0.03 | 0B | NAN% | 0M |
FQ2 2021 (Jun 2021) | -0.08 | -0.08 | 0B | NAN% | 0M |
FQ1 2021 (Mar 2021) | -0.21676 | -0.21676 | 0.000115B | 100% | 0.12M |
FQ4 2020 (Dec 2020) | -0.24 | -0.24 | 8.1E-5B | 100% | 0.08M |
FQ3 2020 (Sep 2020) | -0.48 | -0.36 | 0B | NAN% | 0M |
FQ2 2020 (Jun 2020) | -0.4 | -0.31 | 0B | NAN% | 0M |
FQ1 2020 (Mar 2020) | 1.52 | 1.52 | 0B | NAN% | 0M |
FQ4 Announce Date
06/30/2024 (Pre-Market)
Consensus EPS Estimates
1.34259
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2026 (Mar 2026) | -0.37376 | -- | -0.37376 | -0.37376 | 0 |
FQ4 2025 (Dec 2025) | -0.3871 | -- | -0.3871 | -0.3871 | 0 |
FQ3 2025 (Sep 2025) | -0.32036 | -- | -0.32036 | -0.32036 | 0 |
FQ2 2025 (Jun 2025) | -0.28032 | -- | -0.28032 | -0.28032 | 0 |
FQ1 2025 (Mar 2025) | -0.32036 | -- | -0.32036 | -0.32036 | 0 |
FQ4 2024 (Dec 2024) | -0.4138 | -- | -0.4138 | -0.4138 | 0 |
FQ3 2024 (Sep 2024) | 1.54141 | -- | 1.54141 | 1.54141 | 0 |
FQ2 2024 (Jun 2024) | 1.34259 | -- | 1.34259 | 1.34259 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 0 |
FQ4 2025 (Dec 2025) | 0B | -- | 0B | 0B | 0 |
FQ3 2025 (Sep 2025) | 0B | -- | 0B | 0B | 0 |
FQ2 2025 (Jun 2025) | 0B | -- | 0B | 0B | 0 |
FQ1 2025 (Mar 2025) | 0B | -- | 0B | 0B | 0 |
FQ4 2024 (Dec 2024) | 0B | -- | 0B | 0B | 0 |
FQ3 2024 (Sep 2024) | 0B | -- | 0B | 0B | 0 |
FQ2 2024 (Jun 2024) | 0B | -- | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
2
Revenue # of Misses
0
Revenue # of in-lines
6
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2021 (Dec 2021) | -0.05 | -0.09 | -0.04 | 44.44% |
FQ3 2021 (Sep 2021) | 0.03 | 0.03 | 100% | |
FQ2 2021 (Jun 2021) | -0.08 | -0.08 | 100% | |
FQ1 2021 (Mar 2021) | -0.21676 | -0.21676 | 100% | |
FQ4 2020 (Dec 2020) | -0.24 | -0.24 | 100% | |
FQ3 2020 (Sep 2020) | -0.12 | -0.48 | -0.36 | 75% |
FQ2 2020 (Jun 2020) | -0.09 | -0.4 | -0.31 | 77.5% |
FQ1 2020 (Mar 2020) | 1.52 | 1.52 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2021 (Dec 2021) | $0B | $0B | $0M | NAN% |
FQ3 2021 (Sep 2021) | $0B | $0B | $0M | NAN% |
FQ2 2021 (Jun 2021) | $0B | $0B | $0M | NAN% |
FQ1 2021 (Mar 2021) | $0B | $0B | $0.12M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0B | $0.08M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0B | $0M | NAN% |
FQ2 2020 (Jun 2020) | $0B | $0B | $0M | NAN% |
FQ1 2020 (Mar 2020) | $0B | $0B | $0M | NAN% |